Table 2.
Variable | HR | 95% CI | P |
---|---|---|---|
OS | |||
TERS score | |||
30-37.5 vs ≤29.5 | 1.50 | 1.05-2.14 | .028 |
≥38 vs ≤29.5 | 1.42 | 1.02-2.06 | .049 |
Age, y | |||
≥55 vs <55 | 1.94 | 1.45-2.59 | <.001 |
Disease risk | |||
Intermediate vs low | 1.39 | 0.99-1.95 | .056 |
High vs low | 1.68 | 1.10-2.58 | .018 |
Year of transplantation | |||
2010-2014 vs 2003-2009 | 0.67 | 0.46-0.96 | .029 |
2015-2017 vs 2003-2009 | 0.56 | 0.35-0.88 | .011 |
DFS | |||
TERS score | |||
30-37.5 vs ≤29.5 | 1.36 | 0.99-1.87 | .055 |
≥38 vs ≤29.5 | 1.31 | 0.95-1.80 | .102 |
Age, y | |||
≥55 vs <55 | 1.67 | 1.28-2.17 | <.001 |
Disease risk | |||
High vs low | 1.74 | 1.21-2.49 | .003 |
TRM | |||
TERS score | |||
30-37.5 vs ≤29.5 | 1.91 | 1.14-3.21 | .014 |
≥38 vs ≤29.5 | 1.80 | 1.07-3.04 | .028 |
Age, y | |||
≥55 vs <55 | 1.72 | 1.15-2.56 | .008 |
Relapse | |||
TERS score | |||
30-37.5 vs ≤29.5 | 1.05 | 0.70-1.57 | .820 |
≥38 vs ≤29.5 | 0.99 | 0.66-1.49 | .950 |
Diagnosis | |||
AML vs other | 1.90 | 1.21-2.98 | .005 |
ALL vs other | 2.33 | 1.31-4.13 | .004 |
Disease risk | |||
High vs low | 2.13 | 1.38-3.27 | <.001 |
Intensity | |||
Myeloablative vs nonmyeloablative/RIC | 0.58 | 0.40-0.84 | .004 |